Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck Wins U.S. Approval of New Type of Sleeping Pill
Bloomberg
Wednesday, August 13, 2014 - 4:42pm
tags:
insomnia, Merck, FDA, Belsomra
Ackman says he remains committed to Valeant's bid for Allergan
Yahoo/Reuters
Wednesday, August 13, 2014 - 4:38pm
tags:
Bill Ackman, Valeant Pharmaceuticals, Allergan, M&A
Amgen Drops in After Hours on Failed Trial, Recall
Barron's
Wednesday, August 13, 2014 - 4:36pm
tags:
Amgen, Kyprolis, recalls, Aranesp, Multiple Myeloma
Researchers retract narcolepsy study linked to Glaxo's Pandemrix
Fierce Vaccines
Wednesday, August 13, 2014 - 4:32pm
tags:
GSK, Pandemrix, vaccines, narcolepsy
40% of American adults will develop type 2 diabetes in their lifetime
Medical News Today
Wednesday, August 13, 2014 - 4:28pm
tags:
diabetes
Pharma and physicians slam Sunshine Act for glitches, hassles and cloudy guidelines
Fierce Pharma Marketing
Wednesday, August 13, 2014 - 4:06pm
tags:
physicians, Physician Payment Sunshine Act
Dealpolitik: Allergan Must Tread Carefully as Showdown Looms
WSJ Online
Wednesday, August 13, 2014 - 11:04am
tags:
Allergan, M&A, Valeant Pharmaceuticals
BMS, Pfizer pull out all the stops to give Eliquis sales a Q2 jolt
Fierce Pharma Marketing
Wednesday, August 13, 2014 - 10:34am
tags:
Pfizer, Eliquis, bloodthinners, Bristol-Myers Squibb
When will Merck KGaA take the M&A plunge?
Fierce Biotech
Wednesday, August 13, 2014 - 10:22am
tags:
Merck KGaA, M&A
What the Market is Telling MannKind
24/7 Wall St
Wednesday, August 13, 2014 - 10:20am
tags:
MannKind, Afrezza, insulin, inhaled insulin, Sanofi
Most Popular News Headlines For Tuesday, August 12 2014
CP Wire
Wednesday, August 13, 2014 - 8:54am
tags:
Pfizer, M&A, Boehringer Ingelheim, drug reps, Vertex Pharmaceuticals, Incivek, hepatitis C
Arrowhead Discloses First Human Hepatitis B Therapy Results
TheStreet.com
Wednesday, August 13, 2014 - 8:28am
tags:
hepatitis B, Arrowhead Research, ARC-520
Teva Isn't Moving, for Now, If the Israeli Government Hikes Taxes
TheStreet.com
Wednesday, August 13, 2014 - 8:24am
tags:
Israel, Teva Pharmaceuticals
Rigel experimental eye drug fails mid-stage study
Yahoo/Reuters
Wednesday, August 13, 2014 - 8:23am
tags:
Rigel Pharmaceuticals, R348, dry eye disease
Donor Lung Preservation Device Approved by FDA Could Lead to More Lung Transplants
Pharmacy Times
Wednesday, August 13, 2014 - 8:21am
tags:
devices, FDA, lung transplants, XVIVO Perfusion
Myriad Genetics profit forecast misses estimates
Yahoo/Reuters
Wednesday, August 13, 2014 - 8:18am
tags:
Myriad Genetics
Insys' Q2 sales nearly triple
Yahoo/Investors Business Daily
Wednesday, August 13, 2014 - 8:16am
tags:
earnings, INSYS Therapeutics
AstraZeneca gets pipeline boost from good gout drug results
Yahoo/AP
Wednesday, August 13, 2014 - 8:12am
tags:
gout, AstraZeneca, lesinurad
Communiqué to sales reps: With today's docs, it's the medium and the message
Fierce Pharma Marketing
Tuesday, August 12, 2014 - 7:09pm
tags:
drug reps, physicians
Boehringer to cut costs by 15%
Medical Marketing and Media
Tuesday, August 12, 2014 - 7:06pm
tags:
layoffs, Boehringer Ingelheim

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.